Literature DB >> 19598303

Color Doppler sonography and angioscintigraphy in hepatic Hodgkin's lymphoma.

Mirjana V Stojković1, Vera M Artiko, Irena B Radoman, Slavko J Knezević, Snezana M Lukić, Mirko D Kerkez, Nebojsa S Lekić, Andrija A Antić, Marinko M Zuvela, Vitomir I Ranković, Milorad N Petrović, Dragana P Sobić, Vladimir B Obradović.   

Abstract

AIM: To estimate the characteristics of Color Doppler findings and the results of hepatic radionuclide angiography (HRA) in secondary Hodgkin's hepatic lymphoma.
METHODS: The research included patients with a diagnosis of Hodgkin's lymphoma with metastatic focal lesions in the liver and controls. Morphologic characteristics of focal liver lesions and hemodynamic parameters were examined by pulsed and Color Doppler in the portal, hepatic and splenic veins were examined. Hepatic perfusion index (HPI) estimated by HRA was calculated.
RESULTS: In the majority of patients, hepatomegaly was observed. Lesions were mostly hypoechoic and mixed, solitary or multiple. Some of the patients presented with dilated splenic veins and hepatofugal blood flow. A pulse wave was registered in the centre and at the margins of lymphoma. The average velocity of the pulse wave was higher at the margins (P > 0.05). A continuous venous wave was found only at the margins of lymphoma. There was no linear correlation between lymphoma size and velocity of pulse and continuous wave (r = 390, P < 0.01). HPI was significantly lower in patients with lymphomas than in controls (P < 0.05), pointing out increased arterial perfusion in comparison to portal perfusion.
CONCLUSION: Color Doppler ultrasonography is a sensitive method for the detection of neovascularization in Hodgkin's hepatic lymphoma and estimation of its intensity. Hepatic radionuclide angiography can additionally help in the assessment of vascularisation of liver lesions.

Entities:  

Mesh:

Year:  2009        PMID: 19598303      PMCID: PMC2710783          DOI: 10.3748/wjg.15.3269

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  21 in total

Review 1.  Computerised tomography in the staging of Hodgkin's disease and non-Hodgkin's lymphoma.

Authors:  Sarah J Vinnicombe; Rodney H Reznek
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-04-23       Impact factor: 9.236

2.  Comparison of initial lymphoma staging using computed tomography (CT) and magnetic resonance (MR) imaging.

Authors:  B R Hoane; A F Shields; B A Porter; J W Borrow
Journal:  Am J Hematol       Date:  1994-10       Impact factor: 10.047

3.  A noninvasive method for measuring portal venous/total hepatic blood flow by hepatosplenic radionuclide angiography.

Authors:  R Sarper; W A Fajman; E B Rypins; J M Henderson; Y A Tarcan; J T Galambos; W D Warren
Journal:  Radiology       Date:  1981-10       Impact factor: 11.105

4.  Computerised tomographic (CT) abdominal scanning in Hodgkin's disease.

Authors:  H M Earl; S B Sutcliffe; I K Fry; A K Tucker; J Young; J Husband; P F Wrigley; J S Malpas
Journal:  Clin Radiol       Date:  1980-03       Impact factor: 2.350

Review 5.  Imaging liver metastases: current limitations and future prospects.

Authors:  P J Robinson
Journal:  Br J Radiol       Date:  2000-03       Impact factor: 3.039

6.  Hepatic flow parameters measured with MR imaging and Doppler US: correlations with degree of cirrhosis and portal hypertension.

Authors:  Laurence Annet; Roland Materne; Etienne Danse; Jacques Jamart; Yves Horsmans; Bernard E Van Beers
Journal:  Radiology       Date:  2003-09-11       Impact factor: 11.105

Review 7.  CT Scan and MRI in the Differentiation of Liver Tumors.

Authors:  Masatoshi Hori; Takamichi Murakami; Tonsok Kim; Kaname Tomoda; Hironobu Nakamura
Journal:  Dig Dis       Date:  2004       Impact factor: 2.404

Review 8.  Liver angioscintigraphy: clinical applications.

Authors:  Mircea Dragoteanu; Sabin O Cotul; Cecilia Pîgleşan; Stefan Tamaş
Journal:  Rom J Gastroenterol       Date:  2004-03

9.  Differentiation between benign and malignant hepatic lesions: utility of color stimulated acoustic emission with the microbubble contrast agent Levovist.

Authors:  Alexandra von Herbay; Christoph Vogt; Dieter Häussinger
Journal:  J Ultrasound Med       Date:  2004-02       Impact factor: 2.153

10.  Staging of portal hypertension and portosystemic shunts using dynamic nuclear medicine investigations.

Authors:  Mircea Dragoteanu; Ioan-A Balea; Liliana-A Dina; Cecilia-D Piglesan; Ioana Grigorescu; Stefan Tamas; Sabin-O Cotul
Journal:  World J Gastroenterol       Date:  2008-06-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.